Smartphone vs Manual Interpretation of Biomarkers for Ovulation and Luteal Phase Detection (SMOM Study)
Recruiting
Observational Study
Fertility
Mobile Applications
Artifical Intelligence
Cervical Mucus
Body Temperature
Luteinizing Hormone (LH)
Ovulation
Menstrual Cycle
Progesterone
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 16 – 45
- Sex
- Female
- Study type
- Observational
- Participants needed
- 30 (estimated)
- Sponsor
- Bruyère Health Research Institute. · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study will compare different combinations of fertility signs (cervical mucus (CM), luteinizing hormone \[LH\], pregnanediol glucuronide \[PDG\], and basal body temperature \[BBT\]) to determine which are most reliable for identifying ovulation and luteal phase length. Thirty existing Premom App users will track daily observations for three menstrual cycles. Participants will record mucus, per…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Female, aged 16 to 45
* Natural menstrual cycles equal or less than 35 days
* Off hormonal contraception for more than 3 months
* Current user of the Premom App
* Willing to track cervical mucus, LH, PDG, and BBT for 3 full cycles
* Lives within 50 km of study site in the Otta…
Contacts